Finished Formulations

Accessible and Affordable , Backed by Quality.

At Pharmgenity Health, we are committed to making accessible, high-quality finished formulations available for global healthcare. Manufactured in internationally accredited plants, our products meet the highest international quality and safety standards.

Our wide portfolio of pharmaceuticals and nutraceuticals includes tablets, capsules, injections, syrups, suspensions, and soft gels. Each formulation is developed to comply with pharmacopeial benchmarks — USP, BP, IP, CP, and Nutra Grade — based on formulation type and export requirements.

We ensure strict adherence to quality, safety, and regulatory compliance, delivering trusted formulations worldwide. Customised packing solutions are available as per partner needs, and documents and dossiers are provided on request to support smooth regulatory approvals.

Pharmgenity Health — your trusted partner for accessible, high-quality global healthcare solutions.

Frequently Asked Questions

These FAQs help importers understand what matters most when sourcing finished pharmaceutical formulations for international markets.

Buyers should review dosage form suitability, product stability, packaging format, documentation support, and destination-market compliance before importing finished pharmaceutical formulations from India.

Pharmgenity Health can support multiple finished formulation categories for export, including tablets, capsules, creams, gels, infusions, injections, ointments, sachets, solutions, suspensions, and syrups.

Common export documentation may include product specifications, certificates, batch-related records, packing details, and market-specific regulatory documents depending on the buyer country and product type.

Packaging helps protect product quality during storage and transit, supports labeling compliance, and improves handling across international supply chains.

Yes. Pharmgenity Health works with export-focused supply requirements and can support buyers looking for dependable bulk volumes and market-aligned formulation options.